European Society of Cardiology
Skip navigation links
About the ESC
Guidelines & Surveys
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe

Welcome to congress reports 2013

Stephan Achenbach"It is my pleasure to welcome you to the "Congress Reports" of the ESC 2013 Annual Meeting in Amsterdam. We are about to experience a conference that will exceed all standards and will boost a tremendous amount of clinically relevant and scientifically interesting information.
Especially since most of us are interested in more than just one area, it is impossible to witness even a small amount of all content "live". For this reason, the "Congress Reports" are a welcome source of information: Written usually by session chairpersons, the content of highlighted scientific sessions will be summarized.
Since the "Congress Reports" provide a uniquely useful resource both to the conference attendees and to those who cannot travel to Amsterdam, I was more than delighted to take on the position of Editor-in-Chief.
My special gratitude goes to the reporters who volunteer their time and expertise to create the "Congress Resource" and make them an especially useful piece of information.

Professor Stephan Achenbach, FESC

Access all the pre-arranged reports
Acute Coronary Syndrome
Atria Fibrillation
Basic Science
Cardiovascular Disease Prevention
Cardiovascular Surgery
Chronic Ischaemic Heart Disease
Clinical Pharmacology
Computers in Cardiology
Diabetic Heart Disease
Heart Failure
Infective Endocarditis
Myocardial Disease
Percutaneous Cardiovascular Intervention
Peripheral Arterial Diseases
Rehabilitation and Exercise Physiology
Sudden Cardiac Death and Resuscitation
Thromboembolic Venous Disease
Valvular Heart Diseases
Access the Hot Lines reports

 Hot Lines, Clinical trials and Registries updates

PURE-Sodium: Heterogeneity in the associations of urinary sodium and potassium with blood pressure: The PURE sodium studyAndrew Mente (Hamilton, Canada), Giuseppe Mancia (Milano, Italy)04 Sep 2013
ARCTIC-GENE: ARCTIC-GENEJean-Philippe Collet (Paris, France), Jurrien M Ten Berg (Nieuwegein, Netherlands)04 Sep 2013
TASTE: Prospective Registry based Randomized Clinical Trials (RRCT) - a new concept for clinical researchStefan James (Uppsala, Sweden), Kenneth Mahaffey04 Sep 2013
REGARDS: Optimal blood pressure levels in elderly persons in the reasons for geographic and racial differences in stroke (REGARDS) cohort studyMaciej Banach (Lodz, Poland), David Allan Wood (London, United Kingdom)04 Sep 2013
High-STEACS: High-sensitivity cardiac troponin and the under diagnosis of myocardial infarction in womenNicholas Mills (Edinburgh, United Kingdom), Eva Swahn (Linkoping, Sweden)04 Sep 2013
AMADEUS: Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillationGregory Y H Lip (Birmingham, United Kingdom), Paulus Kirchhof (Birmingham, United Kingdom)04 Sep 2013
ATOMIC-AHF: Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: Results from ATOMIC-AHFJohn R Teerlink (San Francisco, United States of America), McDonagh Teresa (, )03 Sep 2013
AQUARIUS: Effect of the Renin Inhibitor Aliskiren on Progression of Coronary Atherosclerosis: AQUARIUS Study ResultsStephen James Nicholls (Adelaide, Australia), Wolfgang Koenig (Ulm, Germany)03 Sep 2013
BIC-8: Instant early rule-out using cardiac troponin and copeptin in low- to intermediate-risk patients with suspected ACS: A prospective, randomized multicenter studyMartin Moeckel (Berlin, Germany), Bertil Lindahl (Uppsala, Sweden)03 Sep 2013
CHAMPION: Cangrelor for Percutaneous Coronary InterventionChristian Hamm (Bad Nauheim, Germany), Stefan James (Uppsala, Sweden)03 Sep 2013
IABP-SHOCK II: Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic ShockHolger Thiele (Leipzig, Germany), Jan Jacob Piek (Amsterdam, Netherlands)03 Sep 2013
Centenary of the Tour de France Group: Mortality of French Participants from the Tour de France 1947-2012Xavier Jouven (Paris, France), Sanjay Sharma (London, United kingdom)03 Sep 2013
PARTNER: Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for SurgeryBrian Lindman (St. Louis, United States of America), Martine Gilard (Brest Cedex, France)03 Sep 2013
PURE: Contrasting associations between risk factor burden, CVD incidence and mortality in high, middle and low income countriesSalim Yusuf (Hamilton, Canada), Joep Perk (Oskarshamn, SE)02 Sep 2013
SAVOR-TIMI 53: Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 StudyDeepak Bhatt (Newton, United States of America), Michel Komajda (Paris, France)02 Sep 2013
ASSURE: Effect of an Oral Agent Inducing Apo A-I Synthesis on Progression of Coronary Atherosclerosis: Results of the ASSURE StudyStephen James Nicholls (Adelaide, Australia), John Chapman (Paris, France)02 Sep 2013
COMPARE: COMPARE: Effect of losartan on aortic dilatation rate in adults with Marfan SyndromeMaarten Groenink (Amsterdam, Netherlands), Pedro Trigo Trindade (Geneva, Switzerland)02 Sep 2013
Gender Data Forum: Safety and Efficacy of Drug-Eluting Stents in Women: An Individual Patient-Level Pooled Analysis of 26 Randomized Trials Including 11,557 WomenRoxana Mehran (New York, United States of America), Stuart J Pocock (London, United Kingdom)02 Sep 2013
RELAX-AHF: Administration of serelaxin to patients with acute heart failure: are the any differences across RELAX- AHF subgoups?Marco Metra (Brescia, Italy), Schmieder Roland (Erlangen, Gerrmany)02 Sep 2013
ORIGIN: Association between Hypoglycemia and Risk of Cardiovascular Events with Titrated Insulin Glargine or Standard CareLinda Mellbin (Stockholm, Sweden), Peter J Grant (Leeds, United Kingdom)02 Sep 2013
Treatment of venous thromboembolism, the Hokusai VTE studyHarry Buller (Amsterdam, Netherlands), Stavros V Konstantinides (Mainz, Germany)01 Sep 2013
TASTE: Thrombus aspiration during ST-segment elevation myocardial infarction. A multicenter, prospective, registry based randomized clinical trialOle Frobert (Orebro, Sweden), Raffaele De Caterina (Chieti, Italy)01 Sep 2013
TAO: Otamixaban in non-ST-segment elevation acute coronary syndrome patients undergoing a planned invasive strategyPhilippe Gabriel Steg (Paris Cedex 18, France), Christian Hamm (Bad Nauheim, Germany)01 Sep 2013
RE-ALIGN: Dabigatran in patients with a mechanical heart valveFrans Van de Werf (Leuven, Belgium), Alec Vahanian (Paris, France)01 Sep 2013
PARIS: Incidence and Impact of Dual Antiplatelet Therapy Cessation On Adverse Cardiac Events Following Percutaneous Coronary Intervention: Two-Year Results from the Patterns of Non-Adherence to Anti-Platelet Regimens In Stented Patients (PARIS) StudyRoxana Mehran (New York, United States of America), Stephan Windecker (Bern, Switzerland)01 Sep 2013
ACCOAST: A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction.Gilles Montalescot (Paris, France), Marco Roffi (Geneva 14, Switzerland)01 Sep 2013
PRAGUE 14: Perioperative ischemia versus perioperative bleeding in consecutive cardiac patients undergoing non-cardiac surgeryPetr Widimsky (Prague, Czech Republic), Kurt Huber (Vienna, Austria)01 Sep 2013
LINC study: LINC - A multicenter randomized trial comparing a mechanical CPR algorithm using LUCAS vs. manual CPR in out-of-hospital cardiac arrest patientsSten Rubertsson (Uppsala, Sweden), Patrick Goldstein (Lille Cedex, France)01 Sep 2013

 Acute Coronary Syndrome

Novel adjunctive therapies in primary percutaneous coronary interventionHans Erik Botker (Aarhus N, Denmark)Acute Coronary Syndromes (ACS)
ST-elevation myocardial infarction 2013Stuart Spencer (London, United Kingdom)Acute Coronary Syndromes (ACS)


 Atrial Fibrillation

Atrial fibrillation treatment in 2013Philippe Mabo (Rennes Cedex 09, France)Atrial Fibrillation
Ablation of paroxysmal atrial fibrillation: real impact over the long term?Jens Cosedis Nielsen (Aarhus N, Denmark)Atrial Fibrillation
Cutting edge for atrial fibrillation: surgery and hybrid proceduresCarina Blomstrom-Lundqvist (Uppsala, Sweden)Atrial Fibrillation

 Basic Science

Chemotherapy and the heart: what the cardiologist must knowRiccardo Asteggiano (Turin, Italy)Basic Science
Stem cells: unlocking the keysPieter Doevendans (Utrecht, Netherlands)Basic Science
Understanding atrial fibrillation: from molecules to treatmentNiels Voigt (Essen, Germany)Basic Science
Smooth muscle cells: friend or foe in atherosclerosis?Johannes Waltenberger (Muenster, Germany)Basic Science
Blood flow patterns control atherosclerotic plaque developmentAnton Horrevoets (Amsterdam, Netherlands)Basic Science
Mechanisms and clinical implications of coronary microvascular remodellingAxel Radlach Pries (Berlin, Germany)Basic Science
Diastolic heart failure: update on mechanisms and diagnosisBurkert Mathias Pieske (Graz, Austria)Basic Science
Red hot - new insights on inflammation and cardiovascular diseaseHarald HHW Schmidt (Maastricht, Netherlands), A. M. ShahBasic Science

 Cardiovascular Disease Prevention - Risk Assessment and Management

Role of screening in primary preventionTomasz Zdrojewski (Sopot, Poland)Cardiovascular Disease Prevention - Risk Assessment and Management
Critical review of non-statin treatments for dyslipidaemiaChris Packard (Glasgow, United Kingdom)Cardiovascular Disease Prevention - Risk Assessment and Management

 Cardiovascular Surgery

 Chronic Ischaemic Heart Disease (IHD)

Optimal approach to symptomatic stable coronary artery diseaseAlvaro Avezum (Sao Paulo, Brazil)Chronic Ischaemic Heart Disease (IHD)
Together at last: individualising treatment in patients with multivessel coronary artery diseaseMiguel Quinones (Houston, United States of America)Chronic Ischaemic Heart Disease (IHD)
New 2013 ESC Guidelines on stable coronary artery diseaseUdo Sechtem (Stuttgart, Germany)Chronic Ischaemic Heart Disease (IHD)

 Clinical pharmacology

Adipose tissue promoting atherothrombosisLina Badimon (Barcelona, Spain)Clinical pharmacology
What is new in stent thrombosis?Robert F. Storey (Sheffield, United Kingdom)Clinical pharmacology
New oral anticoagulants - clinical challengesJan Steffel (Zurich, Switzerland)Clinical pharmacology
Antiplatelet and antithrombotic therapy after drug-eluting stents: what is next?Nick West (Cambridge, United Kingdom)Clinical pharmacology
Controversies in antiplatelet therapyNeal S Kleiman (Houston, United States of America)Clinical pharmacology
Time for reappraisal of diuretics?Keld Per Kjeldsen (Copenhagen, Denmark)Clinical pharmacology
Drug interactions: what the cardiologist should knowKeld Per Kjeldsen (Copenhagen, Denmark)Clinical pharmacology

 Computers in Cardiology

Imaging and multimodality analyses for patient managementJeroen Bax (Leiden, Netherlands)Computers in Cardiology

 Diabetic heart disease

Is there a role for non-statin based treatments in dyslipidaemia?Alberto Juan Lorenzatti (Cordoba Capital, Argentina)Diabetic heart disease

 Heart Failure

Controversies in peripartum cardiomyopathyJohann Bauersachs (Hannover, Germany)Heart Failure (HF)
Remote monitoring in heart failure: new conceptsEkaterini Lambrinou (Nicosia, Cyprus)Heart Failure (HF)
Challenges in heart failure with preserved ejection fractionWalter Paulus (Amsterdam, Netherlands)Heart Failure (HF)
Cardiology meets oncologyJoerg Herrmann (Rochester, United States of America)Heart Failure (HF)
Evolving indications of cardiac resynchronisation therapyDimitris Tousoulis (Athens, Greece)Heart Failure (HF)


The 2013 ESC/ESH Guidelines for hypertension: hot topicsAntonio Coca (Barcelona, Spain)Hypertension
The 2013 ESH/ESC Guidelines on arterial hypertensionJosep Redon (Valencia, Spain)Hypertension
Diagnosis and treatment of secondary hypertensionMary Marketou (Heraklion, Greece)Hypertension
Stratified approach to resistant hypertensionAnna F Dominiczak (Glasgow, United Kingdom)Hypertension
Novel therapeutic interventions for hypertensionPeter S Sever (London, United Kingdom)Hypertension
Hypertension and the heartPeter Sleight (Oxford, United Kingdom)Hypertension

 Infective Endocarditis

Infective endocarditis - guidelines on trialLuc Pierard (Liege, Belgium)Infective Endocarditis

 Myocardial Disease

Cardiomyopathies: diagnostic clues not to be missedWilliam J McKenna (London, United Kingdom)Myocardial Disease
Dilated cardiomyopathies in systemic disordersPhilippe Charron (Paris, France)Myocardial Disease
Myocarditis in systemic inflammatory diseasesKarin Klingel (Tuebingen, Germany)Myocardial Disease

 Non-invasive imaging: Echocardiography, MR/CT, Nuclear

The future of myocardial perfusion imagingStephen Schroeder (Goeppingen, Germany)Non-invasive imaging: Echocardiography, MR/CT, Nuclear
Does magnetic resonance change clinical management in...Evangelos Giannitsis (Heidelberg, Germany)Non-invasive imaging: Echocardiography, MR/CT, Nuclear
Magnetic resonance imaging in ischaemic heart diseaseChiara Bucciarelli-Ducci (Bristol, United Kingdom)Non-invasive imaging: Echocardiography, MR/CT, Nuclear
Assessment of mitral regurgitation: it is not only the valveErwan Donal (Rennes, France)Non-invasive imaging: Echocardiography, MR/CT, Nuclear
Role of mechanical dyssynchrony in cardiac resynchronisation therapy candidatesJens-Uwe Voigt (Leuven, Belgium)Non-invasive imaging: Echocardiography, MR/CT, Nuclear
Why do we need cardiac imaging in cancer therapy?Lukasz Chrzanowski (Lodz, Poland)Non-invasive imaging: Echocardiography, MR/CT, Nuclear
The tricuspid valve in the spotlightFausto Jose Pinto (Lisbon, Portugal)Non-invasive imaging: Echocardiography, MR/CT, Nuclear
Case-based session - imaging in acute heart failure patients presenting with...Frank Rademakers (Leuven, Belgium)Non-invasive imaging: Echocardiography, MR/CT, Nuclear
Anatomical and functional imaging strategies in chronic coronary artery diseaseStephen Richard Underwood (London, United Kingdom)Non-invasive imaging: Echocardiography, MR/CT, Nuclear
Pitfalls in determining the severity of heart valve diseaseShahbudin Rahimtoola (Los Angeles, United States of America)Non-invasive imaging: Echocardiography, MR/CT, Nuclear


 Percutaneous Cardiovascular Intervention (PCI)

Complications during percutaneous cardiovascular interventionsEric Eeckhout (Lausanne, Switzerland)Percutaneous Cardiovascular Intervention (PCI)
New advances in the treatment of coronary chronic total occlusionThierry LefevrePercutaneous Cardiovascular Intervention (PCI)

 Peripheral Arterial Diseases

Managing asymptomatic carotid disease in patients undergoing coronary artery bypass graftingAlberto Cremonesi (Cotignola, Italy)Peripheral Arterial Diseases
Controversies in lower limb revascularisationCarlo Setacci (Siena, Italy)Peripheral Arterial Diseases

 Rehabilitation and Exercise Physiology

Exercise training: most gain with least pain?Luc Vanhees (Leuven, Belgium)Rehabilitation and Exercise Physiology
Diagnostic dilemmas in sports cardiologyClaudio Araujo (Rio De Janeiro, Brazil), William J McKenna (London, United Kingdom)
Rehabilitation and Exercise Physiology
Physical activity: the universal panacea?Joep Perk (Oskarshamn, Sweden)Rehabilitation and Exercise Physiology

 Sudden Cardiac Death and Resuscitation

Impact of kidney disease on therapy and outcome in patients with acute coronary syndromesDoron Zahger (Beer Sheva, Israel)Sudden Cardiac Death and Resuscitation
New insights into acute pulmonary oedemaVeli-Pekka Harjola (Helsinki, Finland)Sudden Cardiac Death and Resuscitation
Cardiogenic shock - multimodality device therapySusanna Price (London, United Kingdom)Sudden Cardiac Death and Resuscitation
The heart and the brain. Post resuscitation careMarco Tubaro (Rome, Italy)Sudden Cardiac Death and Resuscitation
Surviving cardiopulmonary resuscitationChristian Hassager (Copenhagen, Denmark)Sudden Cardiac Death and Resuscitation
Sudden death in athletesLluis Mont (Barcelona, Spain)Sudden Cardiac Death and Resuscitation


Diagnostic evaluation of syncopeRichard Sutton (Monte Carlo, Monaco)Syncope

 Thromboembolic Venous Disease

Pulmonary embolism: new therapeutic strategiesAdam Torbicki (Otwock, Poland)Thromboembolic Venous Disease

 Valvular Heart Diseases

Transcatheter aortic valve implantation: an ABC for the general cardiologistDavid Messika-Zeitoun (Paris, France)Valvular Heart Diseases
How to evaluate a patient before TAVI - LIVE from BelfastPatrick Donnelly (Belfast, United Kingdom)Valvular Heart Diseases
Challenging clinical scenarios in aortic stenosisOlaf Wendler (London, United Kingdom)Valvular Heart Diseases
Update on percutaneous mitral valve optionsBernard David Prendergast (Oxford, United Kingdom)Valvular Heart Diseases